255 related articles for article (PubMed ID: 30849525)
41. Exploratory algorithm to devise multi-epitope subunit vaccine by investigating Leishmania donovani membrane proteins.
Khatoon N; Pandey RK; Ojha R; Aathmanathan VS; Krishnan M; Prajapati VK
J Biomol Struct Dyn; 2019 Jun; 37(9):2381-2393. PubMed ID: 30047323
[TBL] [Abstract][Full Text] [Related]
42. Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa.
Solanki V; Tiwari M; Tiwari V
Sci Rep; 2019 Mar; 9(1):5240. PubMed ID: 30918289
[TBL] [Abstract][Full Text] [Related]
43. Multi-epitope chimeric vaccine design against emerging Monkeypox virus
Aiman S; Alhamhoom Y; Ali F; Rahman N; Rastrelli L; Khan A; Farooq QUA; Ahmed A; Khan A; Li C
Front Immunol; 2022; 13():985450. PubMed ID: 36091024
[TBL] [Abstract][Full Text] [Related]
44. Prediction of Epitope-Based Peptide Vaccine Against the Chikungunya Virus by Immuno-informatics Approach.
Anwar S; Mourosi JT; Khan MF; Hosen MJ
Curr Pharm Biotechnol; 2020; 21(4):325-340. PubMed ID: 31721709
[TBL] [Abstract][Full Text] [Related]
45. Proteome wide vaccine targets prioritization and designing of antigenic vaccine candidate to trigger the host immune response against the Mycoplasma genitalium infection.
Ali S; Ali S; Javed SO; Shoukat S; Ahmad S; Ali SS; Hussain Z; Waseem M; Rizwan M; Suleman M; Khan A; Wei DQ
Microb Pathog; 2021 Mar; 152():104771. PubMed ID: 33524568
[TBL] [Abstract][Full Text] [Related]
46. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.
Swenson DL; Warfield KL; Negley DL; Schmaljohn A; Aman MJ; Bavari S
Vaccine; 2005 Apr; 23(23):3033-42. PubMed ID: 15811650
[TBL] [Abstract][Full Text] [Related]
47. [Ebola and Marburg viruses: the humans strike back].
Alazard-Dany N; Ottmann Terrangle M; Volchkov V
Med Sci (Paris); 2006 Apr; 22(4):405-10. PubMed ID: 16597410
[TBL] [Abstract][Full Text] [Related]
48. Immunoinformatic and reverse vaccinology-based designing of potent multi-epitope vaccine against Marburgvirus targeting the glycoprotein.
Yousaf H; Naz A; Zaman N; Hassan M; Obaid A; Awan FM; Azam SS
Heliyon; 2023 Aug; 9(8):e18059. PubMed ID: 37534001
[TBL] [Abstract][Full Text] [Related]
49. Immuno-informatics Analysis to Identify Novel Vaccine Candidates and Design of a Multi-Epitope Based Vaccine Candidate Against
Kar PP; Srivastava A
Front Immunol; 2018; 9():2213. PubMed ID: 30374343
[TBL] [Abstract][Full Text] [Related]
50. Immune epitopes identification and designing of a multi-epitope vaccine against bovine leukemia virus: a molecular dynamics and immune simulation approaches.
Samad A; Meghla NS; Nain Z; Karpiński TM; Rahman MS
Cancer Immunol Immunother; 2022 Oct; 71(10):2535-2548. PubMed ID: 35294591
[TBL] [Abstract][Full Text] [Related]
51. Designing multi-epitope vaccine against Staphylococcus aureus by employing subtractive proteomics, reverse vaccinology and immuno-informatics approaches.
Tahir Ul Qamar M; Ahmad S; Fatima I; Ahmad F; Shahid F; Naz A; Abbasi SW; Khan A; Mirza MU; Ashfaq UA; Chen LL
Comput Biol Med; 2021 May; 132():104389. PubMed ID: 33866250
[TBL] [Abstract][Full Text] [Related]
52. The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding.
King LB; Fusco ML; Flyak AI; Ilinykh PA; Huang K; Gunn B; Kirchdoerfer RN; Hastie KM; Sangha AK; Meiler J; Alter G; Bukreyev A; Crowe JE; Saphire EO
Cell Host Microbe; 2018 Jan; 23(1):101-109.e4. PubMed ID: 29324225
[TBL] [Abstract][Full Text] [Related]
53. Proteome-wide screening for designing a multi-epitope vaccine against emerging pathogen
Nain Z; Abdulla F; Rahman MM; Karim MM; Khan MSA; Sayed SB; Mahmud S; Rahman SMR; Sheam MM; Haque Z; Adhikari UK
J Biomol Struct Dyn; 2020 Oct; 38(16):4850-4867. PubMed ID: 31709929
[No Abstract] [Full Text] [Related]
54. An immunoinformatics and structural vaccinology approach to design a novel and potent multi-epitope base vaccine targeting Zika virus.
Hakami MA
BMC Chem; 2024 Feb; 18(1):31. PubMed ID: 38350946
[TBL] [Abstract][Full Text] [Related]
55. Immunoinformatics driven construction of multi-epitope vaccine candidate against
Kaur R; Arora N; Rawat SS; Keshri AK; Singh N; Show SK; Kumar P; Mishra A; Prasad A
Expert Rev Vaccines; 2021 Dec; 20(12):1637-1649. PubMed ID: 34448645
[TBL] [Abstract][Full Text] [Related]
56. Designing of a multi-epitopes-based peptide vaccine against rift valley fever virus and its validation through integrated computational approaches.
Fatima I; Ahmad S; Abbasi SW; Ashfaq UA; Shahid F; Tahir Ul Qamar M; Rehman A; Allemailem KS
Comput Biol Med; 2022 Feb; 141():105151. PubMed ID: 34942394
[TBL] [Abstract][Full Text] [Related]
57. Designing of a Multi-epitope Vaccine against the Structural Proteins of Marburg Virus Exploiting the Immunoinformatics Approach.
Sami SA; Marma KKS; Mahmud S; Khan MAN; Albogami S; El-Shehawi AM; Rakib A; Chakraborty A; Mohiuddin M; Dhama K; Uddin MMN; Hossain MK; Tallei TE; Emran TB
ACS Omega; 2021 Nov; 6(47):32043-32071. PubMed ID: 34870027
[TBL] [Abstract][Full Text] [Related]
58. Rational design of chimeric Multiepitope Based Vaccine (MEBV) against human T-cell lymphotropic virus type 1: An integrated vaccine informatics and molecular docking based approach.
Tariq MH; Bhatti R; Ali NF; Ashfaq UA; Shahid F; Almatroudi A; Khurshid M
PLoS One; 2021; 16(10):e0258443. PubMed ID: 34705829
[TBL] [Abstract][Full Text] [Related]
59. In-silico design of envelope based multi-epitope vaccine candidate against Kyasanur forest disease virus.
Arumugam S; Varamballi P
Sci Rep; 2021 Aug; 11(1):17118. PubMed ID: 34429443
[TBL] [Abstract][Full Text] [Related]
60. Defeating a superbug: A breakthrough in vaccine design against multidrug-resistant Pseudomonas aeruginosa using reverse vaccinology.
Fereshteh S; Haririzadeh Jouriani F; Noori Goodarzi N; Torkamaneh M; Khasheii B; Badmasti F
PLoS One; 2023; 18(8):e0289609. PubMed ID: 37535697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
